300760 迈瑞医疗
交易中 05-30 09:33:06
资讯
新帖
简况
华安证券:给予迈瑞医疗买入评级
证券之星 · 05-25
华安证券:给予迈瑞医疗买入评级
迈瑞医疗:公司目前不涉及您问题中提到的业务
证券之星 · 05-24
迈瑞医疗:公司目前不涉及您问题中提到的业务
5月24日迈瑞医疗现1笔折价20.16%的大宗交易 合计成交1330.19万元
证券之星 · 05-24
5月24日迈瑞医疗现1笔折价20.16%的大宗交易 合计成交1330.19万元
迈瑞医疗(300760.SZ)拟10股派45元 于5月29日除权除息
智通财经网 · 05-22
迈瑞医疗(300760.SZ)拟10股派45元 于5月29日除权除息
迈瑞医疗5月22日现1笔大宗交易 成交金额1393.5万元
智能小浪 · 05-22
迈瑞医疗5月22日现1笔大宗交易 成交金额1393.5万元
5月18日迈瑞医疗现1笔折价19.46%的大宗交易 合计成交1386.78万元
证券之星 · 05-18
5月18日迈瑞医疗现1笔折价19.46%的大宗交易 合计成交1386.78万元
李西廷蝉联新加坡首富,迈瑞医疗的股价却在原地踏步
市场资讯 · 05-17
李西廷蝉联新加坡首富,迈瑞医疗的股价却在原地踏步
CMEF盛会开幕展望医疗未来,迈瑞医疗“三瑞”生态加码智慧医疗建设
财经网 · 05-15
CMEF盛会开幕展望医疗未来,迈瑞医疗“三瑞”生态加码智慧医疗建设
谁是2022年A股高管“薪酬王”?
虎嗅 · 05-15
谁是2022年A股高管“薪酬王”?
迈瑞医疗(300760.SZ)拟12亿元参投有限合伙企业 寻求医疗健康产业投资机会
智通财经 · 05-12
迈瑞医疗(300760.SZ)拟12亿元参投有限合伙企业 寻求医疗健康产业投资机会
5月12日迈瑞医疗现2454.32万元大宗交易
证券之星 · 05-12
5月12日迈瑞医疗现2454.32万元大宗交易
迈瑞医疗致股东信:“黄金”不止十年,拥抱“三个迈瑞”
东方财富 · 05-08
迈瑞医疗致股东信:“黄金”不止十年,拥抱“三个迈瑞”
迈瑞医疗(300760.SZ):强者恒强,迈向全球医疗器械TOP20
格隆汇 · 05-06
迈瑞医疗(300760.SZ):强者恒强,迈向全球医疗器械TOP20
东方证券:给予迈瑞医疗买入评级,目标价位435.6元
证券之星 · 05-04
东方证券:给予迈瑞医疗买入评级,目标价位435.6元
浦银国际证券:给予迈瑞医疗买入评级,目标价位420.0元
证券之星 · 05-04
浦银国际证券:给予迈瑞医疗买入评级,目标价位420.0元
主打一个稳健!迈瑞医疗2022年营收破300亿 持续推进高端化、国际化
新浪财经 · 04-28
主打一个稳健!迈瑞医疗2022年营收破300亿 持续推进高端化、国际化
迈瑞医疗2022年每股收益7.94元 营收净利双增凸显龙头韧性
中国基金报 · 04-27
迈瑞医疗2022年每股收益7.94元 营收净利双增凸显龙头韧性
图解迈瑞医疗年报:第四季度单季净利润同比增12.41%
证券之星 · 04-27
图解迈瑞医疗年报:第四季度单季净利润同比增12.41%
迈瑞医疗(300760.SZ)发布一季度业绩,净利润25.71亿元,同比增长22.14%
智通财经 · 04-27
迈瑞医疗(300760.SZ)发布一季度业绩,净利润25.71亿元,同比增长22.14%
迈瑞医疗(300760.SZ)发布2022年度业绩,净利润96.07亿元,同比增长20.07%,拟每10股派45元
智通财经 · 04-27
迈瑞医疗(300760.SZ)发布2022年度业绩,净利润96.07亿元,同比增长20.07%,拟每10股派45元
加载更多
公司概况
公司名称:
深圳迈瑞生物医疗电子股份有限公司
所属行业:
专用设备制造业
上市日期:
2018-10-16
主营业务:
深圳迈瑞生物医疗电子股份有限公司主要从事医疗器械的研发、制造、营销及服务,主要产品涵盖三大领域:生命信息与支持、体外诊断以及医学影像。公司总部设在中国深圳,在北美、欧洲、亚洲、非洲、拉美等地区的超过30个国家设有40家境外子公司;在国内设有17家子公司,超过40家分支机构,形成了庞大的全球化研发、营销及服务网络。在2019年公布的第五批优秀国产医疗设备产品目录中,公司共有4个型号的全自动尿液工作站、5个型号的除颤仪、8个型号的腹腔镜、7个型号的注射泵、6个型号的输液泵、6个型号的便携式输液泵以及2个型号的输注工作站入选。
发行价格:
48.80
{"stockData":{"symbol":"300760","market":"SZ","secType":"STK","nameCN":"迈瑞医疗","latestPrice":312.49,"timestamp":1685410386000,"preClose":312.02,"halted":0,"volume":110750,"delay":0,"floatShares":1212000000,"shares":1212000000,"eps":8.3083,"marketStatus":"交易中","marketStatusCode":2,"change":0.47,"latestTime":"05-30 09:33:06","open":314.2,"high":314.2,"low":312.13,"amount":34678200,"amplitude":0.0066,"askPrice":312.8,"askSize":1,"bidPrice":312.51,"bidSize":1,"shortable":0,"etf":0,"ttmEps":8.3083,"tradingStatus":2,"nextMarketStatus":{"tag":"午间休市","tradingStatus":4,"beginTime":1685417400000},"adr":0,"adjPreClose":312.02,"symbolType":"stock","highLimit":343.22,"lowLimit":280.82,"ibTradeSell":false,"ibTradeBuySell":false,"totalEquity":1212441394,"pbRate":10.92,"roa":"--","roe":"7.72%","epsLYR":7.9402,"committee":0.212121,"marketValue":378876000000,"floatMarketCap":378876000000,"peRate":37.611786,"changeRate":0.0015,"turnoverRate":0.0001,"status":0},"requestUrl":"/m/hq/s/300760","defaultTab":"news","newsList":[{"id":"2338166262","title":"华安证券:给予迈瑞医疗买入评级","url":"https://stock-news.laohu8.com/highlight/detail?id=2338166262","media":"证券之星","top":-1,"share":"https://www.laohu8.com/m/news/2338166262?lang=zh_CN&edition=full","pubTime":"2023-05-25 17:51","pubTimestamp":1685008269,"startTime":"0","endTime":"0","summary":null,"market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2023052500026089.shtml","is_publish_highlight":false},{"id":"2337538921","title":"迈瑞医疗:公司目前不涉及您问题中提到的业务","url":"https://stock-news.laohu8.com/highlight/detail?id=2337538921","media":"证券之星","top":-1,"share":"https://www.laohu8.com/m/news/2337538921?lang=zh_CN&edition=full","pubTime":"2023-05-24 16:55","pubTimestamp":1684918539,"startTime":"0","endTime":"0","summary":null,"market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2023052400023453.shtml","is_publish_highlight":false},{"id":"2337219279","title":"5月24日迈瑞医疗现1笔折价20.16%的大宗交易 合计成交1330.19万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2337219279","media":"证券之星","top":-1,"share":"https://www.laohu8.com/m/news/2337219279?lang=zh_CN&edition=full","pubTime":"2023-05-24 16:54","pubTimestamp":1684918472,"startTime":"0","endTime":"0","summary":null,"market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2023052400023352.shtml","is_publish_highlight":false},{"id":"2337447796","title":"迈瑞医疗(300760.SZ)拟10股派45元 于5月29日除权除息","url":"https://stock-news.laohu8.com/highlight/detail?id=2337447796","media":"智通财经网","top":-1,"share":"https://www.laohu8.com/m/news/2337447796?lang=zh_CN&edition=full","pubTime":"2023-05-22 17:37","pubTimestamp":1684748221,"startTime":"0","endTime":"0","summary":"智通财经APP讯,迈瑞医疗(300760.SZ)公告,公司2022年度权益分派拟向全体股东每10股派45.00元(含税)。除权除息日为:2023年5月29日。更多港股重磅资讯,下载智通财经app更多港股及海外理财资讯,请点击www.zhitongcaijing.com(搜索“智通财经”);欲加入智通港股投资群,请加智通客服微信(ztcjkf)","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/933838.html","is_publish_highlight":false},{"id":"2337649728","title":"迈瑞医疗5月22日现1笔大宗交易 成交金额1393.5万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2337649728","media":"智能小浪","top":-1,"share":"https://www.laohu8.com/m/news/2337649728?lang=zh_CN&edition=full","pubTime":"2023-05-22 17:01","pubTimestamp":1684746060,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"sina","url":"https://finance.sina.com.cn/stock/ggzz/2023-05-22/doc-imyurxxz3044920.shtml","rn_cache_url":null,"customStyle":"body{padding-top:10px;}.art_tit_h1{#titleStyle#}a{#lv2TextColor#}.art_time, .art_cite{#sourceStyle#;} .art_cite{margin-left: 3px;}","selectors":".module-article, article","filters":"header, .voice2, .tags, #norm_qrcode_link_auto, .unfold-box, .action","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/ggzz/2023-05-22/doc-imyurxxz3044920.shtml","is_publish_highlight":false},{"id":"2336318306","title":"5月18日迈瑞医疗现1笔折价19.46%的大宗交易 合计成交1386.78万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2336318306","media":"证券之星","top":-1,"share":"https://www.laohu8.com/m/news/2336318306?lang=zh_CN&edition=full","pubTime":"2023-05-18 16:58","pubTimestamp":1684400307,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2023051800023317.shtml","is_publish_highlight":false},{"id":"2336353292","title":"李西廷蝉联新加坡首富,迈瑞医疗的股价却在原地踏步","url":"https://stock-news.laohu8.com/highlight/detail?id=2336353292","media":"市场资讯","top":-1,"share":"https://www.laohu8.com/m/news/2336353292?lang=zh_CN&edition=full","pubTime":"2023-05-17 09:25","pubTimestamp":1684286700,"startTime":"0","endTime":"0","summary":null,"market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"sina","url":"https://finance.sina.com.cn/stock/med/ylqx/2023-05-17/doc-imytzxmk6155902.shtml","rn_cache_url":null,"customStyle":"body{padding-top:10px;}.art_tit_h1{#titleStyle#}a{#lv2TextColor#}.art_time, .art_cite{#sourceStyle#;} .art_cite{margin-left: 3px;}","selectors":".module-article, article","filters":"header, .voice2, .tags, #norm_qrcode_link_auto, .unfold-box, .action","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/med/ylqx/2023-05-17/doc-imytzxmk6155902.shtml","is_publish_highlight":false},{"id":"2335837361","title":"CMEF盛会开幕展望医疗未来,迈瑞医疗“三瑞”生态加码智慧医疗建设","url":"https://stock-news.laohu8.com/highlight/detail?id=2335837361","media":"财经网","top":-1,"share":"https://www.laohu8.com/m/news/2335837361?lang=zh_CN&edition=full","pubTime":"2023-05-15 12:08","pubTimestamp":1684123680,"startTime":"0","endTime":"0","summary":null,"market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"sina","url":"https://finance.sina.com.cn/roll/2023-05-15/doc-imytvrnw7753178.shtml","rn_cache_url":null,"customStyle":"body{padding-top:10px;}.art_tit_h1{#titleStyle#}a{#lv2TextColor#}.art_time, .art_cite{#sourceStyle#;} .art_cite{margin-left: 3px;}","selectors":".module-article, article","filters":"header, .voice2, .tags, #norm_qrcode_link_auto, .unfold-box, .action","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://finance.sina.com.cn/roll/2023-05-15/doc-imytvrnw7753178.shtml","is_publish_highlight":false},{"id":"2335334088","title":"谁是2022年A股高管“薪酬王”?","url":"https://stock-news.laohu8.com/highlight/detail?id=2335334088","media":"虎嗅","top":-1,"share":"https://www.laohu8.com/m/news/2335334088?lang=zh_CN&edition=full","pubTime":"2023-05-15 08:52","pubTimestamp":1684111928,"startTime":"0","endTime":"0","summary":"“第一”董秘法学出身","market":"sh","thumbnail":"https://img.huxiucdn.com/article/cover/202305/15/082948249486.jpg?imageView2/1/w/720/h/405/|imageMogr2/strip/interlace/1/quality/85/format/jpg","type":0,"news_type":0,"thumbnails":["https://img.huxiucdn.com/article/cover/202305/15/082948249486.jpg?imageView2/1/w/720/h/405/|imageMogr2/strip/interlace/1/quality/85/format/jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.huxiu.com/article/1554420.html","is_publish_highlight":false},{"id":"2334016403","title":"迈瑞医疗(300760.SZ)拟12亿元参投有限合伙企业 寻求医疗健康产业投资机会","url":"https://stock-news.laohu8.com/highlight/detail?id=2334016403","media":"智通财经","top":-1,"share":"https://www.laohu8.com/m/news/2334016403?lang=zh_CN&edition=full","pubTime":"2023-05-12 22:08","pubTimestamp":1683900506,"startTime":"0","endTime":"0","summary":"智通财经APP讯,迈瑞医疗(300760.SZ)公告,公司拟与晨壹基金管理(北京)有限公司(含其全资子公司)共同投资有限合伙企业,其中公司拟作为有限合伙人以自有资金认缴出资额12亿元。本次设立的合伙企业投资方向为:医疗健康产业优质股权投资机会。公告称,本次参与投资符合公司战略,在保证主营业务稳健发展的前提下,有助于加快公司发展战略的实施,依托专业投资机构的专业团队优势、项目资源优势和平台优势,积极寻找具有良好发展前景的项目,能有效降低公司的投资风险,促进公司业绩增长。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/929962.html","is_publish_highlight":false},{"id":"2334615060","title":"5月12日迈瑞医疗现2454.32万元大宗交易","url":"https://stock-news.laohu8.com/highlight/detail?id=2334615060","media":"证券之星","top":-1,"share":"https://www.laohu8.com/m/news/2334615060?lang=zh_CN&edition=full","pubTime":"2023-05-12 17:09","pubTimestamp":1683882563,"startTime":"0","endTime":"0","summary":"5月12日迈瑞医疗发生大宗交易,交易数据如下:大宗交易成交价格306.79元,成交8万股,成交金额2454.32万元,买方营业部为中信建投证券股份有限公司济南和平路证券营业部,卖方营业部为招商证券交易单元。近三个月该股共发生23笔大宗交易,合计成交1.5万手,折价成交17笔,溢价成交1笔。截至2023年5月12日收盘,迈瑞医疗报收于306.79元,上涨0.9%,换手率0.21%,成交量2.56万手,成交额7.89亿元。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2023051200023880.shtml","is_publish_highlight":false},{"id":"2333288861","title":"迈瑞医疗致股东信:“黄金”不止十年,拥抱“三个迈瑞”","url":"https://stock-news.laohu8.com/highlight/detail?id=2333288861","media":"东方财富","top":-1,"share":"https://www.laohu8.com/m/news/2333288861?lang=zh_CN&edition=full","pubTime":"2023-05-08 16:20","pubTimestamp":1683534000,"startTime":"0","endTime":"0","summary":"彼时,我国持续加大政策扶持,国产医疗器械产业发展迅速,李西廷做出了中国医疗器械产业进入“黄金十年”的预判。面对我国医疗产业长期持续发展的确定性和外部环境的不确定性,李西廷表示,将继续在自主创新的道路上笃定前行,以“三个迈瑞”迎接挑战和机遇,拥抱“创新的迈瑞、引领的迈瑞、全球的迈瑞”。创新的迈瑞,为全球医疗机构创造更多价值“正是对创新探索的执著,才成就了今日的迈瑞。”李西廷在致股东信中直言。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"sina","url":"https://finance.sina.com.cn/stock/relnews/cn/2023-05-08/doc-imytaefs1966845.shtml","rn_cache_url":null,"customStyle":"body{padding-top:10px;}.art_tit_h1{#titleStyle#}a{#lv2TextColor#}.art_time, .art_cite{#sourceStyle#;} .art_cite{margin-left: 3px;}","selectors":".module-article, article","filters":"header, .voice2, .tags, #norm_qrcode_link_auto, .unfold-box, .action","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/relnews/cn/2023-05-08/doc-imytaefs1966845.shtml","is_publish_highlight":false},{"id":"2333559524","title":"迈瑞医疗(300760.SZ):强者恒强,迈向全球医疗器械TOP20","url":"https://stock-news.laohu8.com/highlight/detail?id=2333559524","media":"格隆汇","top":-1,"share":"https://www.laohu8.com/m/news/2333559524?lang=zh_CN&edition=full","pubTime":"2023-05-06 10:26","pubTimestamp":1683340013,"startTime":"0","endTime":"0","summary":"对比起全球医疗器械TOP1营收高达300亿美元,就知道迈瑞医疗这份300亿人民币的营收成绩单仅仅只是一个开始,后续的路还很长,向上的天花板仍非常高。","market":"hk","thumbnail":"https://img2.gelonghui.com/afa47-933496bb-ada1-4fdf-bf06-1a685e6058fb.png","type":0,"news_type":0,"thumbnails":["https://img2.gelonghui.com/afa47-933496bb-ada1-4fdf-bf06-1a685e6058fb.png"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.gelonghui.com/p/601018","is_publish_highlight":false},{"id":"2332154779","title":"东方证券:给予迈瑞医疗买入评级,目标价位435.6元","url":"https://stock-news.laohu8.com/highlight/detail?id=2332154779","media":"证券之星","top":-1,"share":"https://www.laohu8.com/m/news/2332154779?lang=zh_CN&edition=full","pubTime":"2023-05-04 17:53","pubTimestamp":1683194037,"startTime":"0","endTime":"0","summary":"东方证券股份有限公司近期对迈瑞医疗进行研究并发布了研究报告《迈瑞医疗年报&一季报点评:国内业务不断恢复,国际受高端客户群突破带动空间不断打开》,本报告对迈瑞医疗给出买入评级,认为其目标价位为435.60元,当前股价为315.0元,预期上涨幅度为38.29%。最新盈利预测明细如下:该股最近90天内共有27家机构给出评级,买入评级25家,增持评级2家;过去90天内机构目标均价为429.49。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2023050400018656.shtml","is_publish_highlight":false},{"id":"2332207154","title":"浦银国际证券:给予迈瑞医疗买入评级,目标价位420.0元","url":"https://stock-news.laohu8.com/highlight/detail?id=2332207154","media":"证券之星","top":-1,"share":"https://www.laohu8.com/m/news/2332207154?lang=zh_CN&edition=full","pubTime":"2023-05-04 17:53","pubTimestamp":1683193989,"startTime":"0","endTime":"0","summary":"浦银国际证券有限公司近期对迈瑞医疗进行研究并发布了研究报告《2022与1Q23业绩符合预期,IVD业务稍受疫情拖累》,本报告对迈瑞医疗给出买入评级,认为其目标价位为420.00元,当前股价为315.0元,预期上涨幅度为33.33%。 维持“买入”评级及目标价420元人民币。最新盈利预测明细如下:该股最近90天内共有27家机构给出评级,买入评级25家,增持评级2家;过去90天内机构目标均价为429.49。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2023050400018621.shtml","is_publish_highlight":false},{"id":"2330752059","title":"主打一个稳健!迈瑞医疗2022年营收破300亿 持续推进高端化、国际化","url":"https://stock-news.laohu8.com/highlight/detail?id=2330752059","media":"新浪财经","top":-1,"share":"https://www.laohu8.com/m/news/2330752059?lang=zh_CN&edition=full","pubTime":"2023-04-28 21:38","pubTimestamp":1682689080,"startTime":"0","endTime":"0","summary":" 近日,医疗器械巨头迈瑞医疗发布了2022年报及2023年1季报。 2022年,迈瑞医疗实现营收303.66亿元,同比增长20.17%,其中单Q4营收70.7亿元,同比增长20.28%%。2022年及今年Q1实现归母净利润96.07亿元、25.71亿元,分别同比增长20.07%、22.14%,利润端增速亦有提升。 2022年,迈瑞医疗三大业务均实现稳健增长,生命信息与支持业务实现营收134.01亿元,同比增长20.15%,主要受益于国内医疗新基建和海外高端突破的持续推进。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"sina","url":"https://finance.sina.com.cn/stock/observe/2023-04-28/doc-imyrxzvp4033392.shtml","rn_cache_url":null,"customStyle":"body{padding-top:10px;}.art_tit_h1{#titleStyle#}a{#lv2TextColor#}.art_time, .art_cite{#sourceStyle#;} .art_cite{margin-left: 3px;}","selectors":".module-article, article","filters":"header, .voice2, .tags, #norm_qrcode_link_auto, .unfold-box, .action","directOrigin":true},"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/observe/2023-04-28/doc-imyrxzvp4033392.shtml","is_publish_highlight":false},{"id":"2330538796","title":"迈瑞医疗2022年每股收益7.94元 营收净利双增凸显龙头韧性","url":"https://stock-news.laohu8.com/highlight/detail?id=2330538796","media":"中国基金报","top":-1,"share":"https://www.laohu8.com/m/news/2330538796?lang=zh_CN&edition=full","pubTime":"2023-04-27 21:15","pubTimestamp":1682601300,"startTime":"0","endTime":"0","summary":"4月27日,迈瑞医疗披露2022年年报。同日,迈瑞医疗发布的2023年一季报,营收和归母净利润延续双增长趋势,龙头韧性凸显。一季报显示,2023年一季度,公司实现营业收入83.64亿元,同比增长20.47%;实现归母净利润25.71亿元,同比增长22.14%。2022年年报数据即显示,迈瑞医疗境外营收规模站稳百亿大关,达116.98亿元,延续增长态势。截至2023年12月31日,迈瑞医疗共计申请专利8670件,其中发明专利6193件;共计授权专利3976件,其中发明专利授权1847件。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":null,"url":"http://du.sov5.cn/t/OE1PeUhEbEZ5bA==","rn_cache_url":null,"directOrigin":true},"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://du.sov5.cn/t/OE1PeUhEbEZ5bA==","is_publish_highlight":false},{"id":"2330791588","title":"图解迈瑞医疗年报:第四季度单季净利润同比增12.41%","url":"https://stock-news.laohu8.com/highlight/detail?id=2330791588","media":"证券之星","top":-1,"share":"https://www.laohu8.com/m/news/2330791588?lang=zh_CN&edition=full","pubTime":"2023-04-27 18:40","pubTimestamp":1682592059,"startTime":"0","endTime":"0","summary":"迈瑞医疗2022年报显示,公司主营收入303.66亿元,同比上升20.17%;归母净利润96.07亿元,同比上升20.07%;扣非净利润95.25亿元,同比上升21.33%;其中2022年第四季度,公司单季度主营收入70.7亿元,同比上升20.27%;单季度归母净利润15.05亿元,同比上升12.41%;单季度扣非净利润15.21亿元,同比上升16.48%;负债率31.55%,投资收益-506.14万元,财务费用-4.51亿元,毛利率64.15%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2023042700033203.shtml","is_publish_highlight":false},{"id":"2330430787","title":"迈瑞医疗(300760.SZ)发布一季度业绩,净利润25.71亿元,同比增长22.14%","url":"https://stock-news.laohu8.com/highlight/detail?id=2330430787","media":"智通财经","top":-1,"share":"https://www.laohu8.com/m/news/2330430787?lang=zh_CN&edition=full","pubTime":"2023-04-27 18:10","pubTimestamp":1682590254,"startTime":"0","endTime":"0","summary":"智通财经APP讯,迈瑞医疗(300760.SZ)披露2023年第一季度报告,公司营业收入83.64亿元,同比增长20.47%;归属于上市公司股东的净利润25.71亿元,同比增长22.14%;归属于上市公司股东的扣除非经常性损益的净利润25.29亿元,同比增长22.05%;基本每股收益2.1260元。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/921346.html","is_publish_highlight":false},{"id":"2330307830","title":"迈瑞医疗(300760.SZ)发布2022年度业绩,净利润96.07亿元,同比增长20.07%,拟每10股派45元","url":"https://stock-news.laohu8.com/highlight/detail?id=2330307830","media":"智通财经","top":-1,"share":"https://www.laohu8.com/m/news/2330307830?lang=zh_CN&edition=full","pubTime":"2023-04-27 18:07","pubTimestamp":1682590040,"startTime":"0","endTime":"0","summary":"智通财经APP讯,迈瑞医疗(300760.SZ)披露2022年年度报告,该公司营业收入303.66亿元,同比增长20.17%;归属于上市公司股东的净利润96.07亿元,同比增长20.07%;归属于上市公司股东的扣除非经常性损益的净利润95.25亿元,同比增长21.33%;基本每股收益7.9402元。此外,公司拟向全体股东每10股派发现金红利45元(含税)。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/921332.html","is_publish_highlight":false}],"profile":{"ret":0,"listingDate":"2018-10-16","address":"广东省深圳市南山区高新技术产业园区科技南十二路迈瑞大厦1-4层","stockEarnings":[{"period":"1week","weight":0.0112},{"period":"1month","weight":0.0148},{"period":"3month","weight":0.0079},{"period":"6month","weight":-0.0249},{"period":"1year","weight":0.0732},{"period":"ytd","weight":0.0017}],"companyName":"深圳迈瑞生物医疗电子股份有限公司","boardCode":"AI0035","perCapita":"19214股","boardName":"专用设备制造业","registeredCapital":"121244万元","compareEarnings":[{"period":"1week","weight":-0.0228},{"period":"1month","weight":-0.0306},{"period":"3month","weight":-0.0177},{"period":"6month","weight":0.0222},{"period":"1year","weight":0.0291},{"period":"ytd","weight":0.0428}],"survey":" 深圳迈瑞生物医疗电子股份有限公司主要从事医疗器械的研发、制造、营销及服务,主要产品涵盖三大领域:生命信息与支持、体外诊断以及医学影像。公司总部设在中国深圳,在北美、欧洲、亚洲、非洲、拉美等地区的超过30个国家设有40家境外子公司;在国内设有17家子公司,超过40家分支机构,形成了庞大的全球化研发、营销及服务网络。在2019年公布的第五批优秀国产医疗设备产品目录中,公司共有4个型号的全自动尿液工作站、5个型号的除颤仪、8个型号的腹腔镜、7个型号的注射泵、6个型号的输液泵、6个型号的便携式输液泵以及2个型号的输注工作站入选。","serverTime":1685410391392,"listedPrice":48.8,"stockholders":"63099人(较上一季度减少3.84%)","compareStock":{"symbol":"000001.SH","name":"上证指数"}},"APP":{"userAgent":"CCBot/2.0 (https://commoncrawl.org/faq/)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.13.0","shortVersion":"4.13.0","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"迈瑞医疗(300760)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供迈瑞医疗(300760)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"迈瑞医疗,300760,迈瑞医疗股票,迈瑞医疗股票老虎,迈瑞医疗股票老虎国际,迈瑞医疗行情,迈瑞医疗股票行情,迈瑞医疗股价,迈瑞医疗股市,迈瑞医疗股票价格,迈瑞医疗股票交易,迈瑞医疗股票购买,迈瑞医疗股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"迈瑞医疗(300760)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供迈瑞医疗(300760)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}